INIS
patients
100%
coronaries
88%
diseases
76%
arteries
67%
proteins
61%
heart failure
51%
drugs
46%
kinases
45%
mortality
45%
rats
41%
females
39%
hospitals
38%
genes
34%
myocardial infarction
34%
reviews
32%
genotype
27%
data
27%
humans
26%
therapy
25%
sex
25%
ischemia
25%
levels
24%
microtubules
22%
risks
22%
genetics
21%
homeostasis
20%
traps
20%
sex dependence
20%
coronaviruses
20%
modifications
20%
Keyphrases
Left Ventricular Ejection Fraction
45%
Troponin
44%
Ejection Fraction
43%
Obstructive Coronary Artery Disease
41%
Baseline Characteristics
41%
Heart Failure with Preserved Ejection Fraction (HFpEF)
32%
Clinical Significance
24%
Long QT Syndrome
24%
Left Ventricular Dysfunction
24%
Cardiomyocytes
24%
Heart Failure
24%
Ischemia
22%
Pressure Overload
22%
Long-term Mortality
22%
Myocardial Infarction
22%
Non-obstructive Coronary Artery Disease
22%
Tropism
20%
Neutrophil Extracellular Traps
20%
COVID-19
20%
Sex-specific
20%
Myofilament Proteins
20%
Cardiac Homeostasis
20%
Dependent Development
20%
Cytoskeleton
20%
Hypertensive Rats
20%
Cardiovascular Remodeling
20%
Virus
20%
Pharmacological Therapy
20%
Post-translational Modification
20%
Gene Variants
20%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
51%
Heart Infarction
41%
Troponin
41%
Infection
25%
Ischemia
25%
All Cause Mortality
25%
Heart Arrhythmia
25%
Long QT Syndrome
25%
Cardiovascular Disease
25%
Heart Failure with Preserved Ejection Fraction
24%
SARS Coronavirus
20%
ZSF1 Rat
20%
Cyclic GMP
20%
Actin
20%
Phosphodiesterase
20%
Heart Injury
20%
Congenital Heart Disease
20%
Cardiac Channelopathy
20%
Short QT Syndrome
20%
Left Ventricular Diastolic Dysfunction
20%
Rat Model
20%
Channelopathy
20%
Capillary Rarefaction
20%
Cyclic GMP Dependent Protein Kinase
20%
Brugada Syndrome
19%
Disease
16%
Catecholaminergic Polymorphic Ventricular Tachycardia
13%
Pharmacotherapy
13%
Comorbidity
12%
Adverse Event
10%